Responses
Regular and Young Investigator Award Abstracts
Clinical Trials Completed
582 Patient-reported outcomes with cemiplimab versus chemotherapy in advanced non-small cell lung cancer (aNSCLC): Eastern cooperative oncology group (ECOG) performance status subgroups in EMPOWER-Lung 1
Compose a Response to This Article
Other responses
No responses have been published for this article.